Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate

M Vartiainen, H De Gezelle… - The European Journal of …, 2001 - Taylor & Francis
Objective: To investigate the effect of a combiphasic oral contraceptive containing
ethinylestradiol and desogestrel (combiphasic EE/DSG) on acne, compared with a …

A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial

U Jaisamrarn, S Chaovisitsaree, S Angsuwathana… - Contraception, 2014 - Elsevier
Objective This study aimed to compare the effectiveness and safety of triphasic combined
oral contraceptives (OCs) containing ethinyl estradiol (EE) and norgestimate (NGM) and …

Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo …

E Palombo-Kinne, I Schellschmidt, U Schumacher… - Contraception, 2009 - Elsevier
BACKGROUND: Acne is a multifactorial disease characterized by androgenic stimulation of
sebaceous glands. Therefore, combined oral contraceptives (COCs) containing anti …

[PDF][PDF] Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate

C Charoenvisal, Y Thaipisuttikul, S Pinjaroen… - 1996 - repository.ubn.ru.nl
Objective—To compare the effects of a low-dose oral contraceptive containing desogestrel
(Marvelon) and an anti-androgenic preparation containing cyproterone acetate (Diane) in …

A randomized controlled trial of second-versus third-generation oral contraceptives in the treatment of acne vulgaris

MP Rosen, DM Breitkopf, M Nagamani - American journal of obstetrics and …, 2003 - Elsevier
Objective: This study was undertaken to compare the clinical efficacy of second-versus third-
generation oral contraceptives in the treatment of acne. Study Design: Thirty-four women …

A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany

ML Vree, J Schmidt - The European Journal of Contraception & …, 2001 - Taylor & Francis
Objective The aim of this observational study was to assess the influence of a new
combiphasic oral contraceptive on cycle control, tolerability and acne in a large cohort of …

Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3 mg administered in a 24/4 regimen: a …

W Koltun, JM Maloney, J Marr, M Kunz - European Journal of Obstetrics & …, 2011 - Elsevier
OBJECTIVE: To investigate the effects of an ethinylestradiol (EE) 20μg/drospirenone (drsp)
3mg combined oral contraceptive (COC) administered in a 24/4 regimen (24 active tablets/4 …

Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase …

G Plewig, WJ Cunliffe, N Binder, K Höschen - Contraception, 2009 - Elsevier
BACKGROUND: The study was conducted to assess the effects of the monophasic
combined oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone …

Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris …

PG Sator, JB Schmidt, H Hönigsmann - Dermatology, 2003 - karger.com
Abstract Background and Objective: The aim of this study was to evaluate the efficacy of a
triphasic combination oral contraceptive (OC) containing norgestimate and ethinyl estradiol …

Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne: results of a multicenter study

L Carlborg - Acta Obstetricia et Gynecologica Scandinavica, 1986 - Wiley Online Library
In spite of an abundant literature on antiandrogen treatment with cyproterone acetate (CA)
there have been no objectively measured results to prove statistically the possible …